Dexcom Inc. has been given approval for the first remote mobile communications device used for continuous glucose monitoring (CGM).
Dexcom SHARE
A leader in CGM, Dexcom were granted approval from the U.S Food and Drug Administration for the Dexcom SHARE device. This uses a wireless connection to transmit the glucose levels of a person with diabetes, which can be received on smartphones by up to five people.
These people, or “followers”, can remotely monitor this glucose information and receive the location of the person with diabetes and alert notifications on an Apple iPhone or iPod touch.
“Dexcom SHARE represents a significant advance in diabetes care by allowing people with diabetes to share important glucose information with their loved ones from afar,” explained Terrance H. Gregg, Chief Executive Officer of Dexcom Inc.
Dexcom SHARE uses Bluetooth technology and uploads data to a secure server, with the device hailed as a big development in diabetes care.
“The ability to share the continuous glucose data remotely, to almost any locatio, is a remarkable advance,” said Lori Laffel, M.D., M.P.H., Chief of the Pediatric, Adolescent and Young Adult section, Joslin Diabetes Centre, in Bosto, MA.
Benefits to diabetes
The Dexcom SHARE allows parents and personal caregivers can monitor a child’s or loved one’s glucose data and will be alerted when levels are too high or low.
Over 3.2 million people in the United Kingdom have diabetes, and while a distribution time frame in the UK has not yet been made clear, this is an exciting development.
Young people with diabetes require constant supervision, and this device, as well as those that will follow in its footsteps, will enable excellent diabetes control from an early age.
What's new on the forum? ⭐️
Get our free newsletters
Stay up to date with the latest news, research and breakthroughs.